Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1988 Jan;47(1):28–33. doi: 10.1136/ard.47.1.28

Pulse steroid therapy in rheumatoid arthritis: can equivalent doses of oral prednisolone give similar clinical results to intravenous methylprednisolone?

M D Smith 1, M J Ahern 1, P J Roberts-Thomson 1
PMCID: PMC1003439  PMID: 3278694

Abstract

Pulse methylprednisolone therapy has dramatic effects on clinical and immunological parameters of disease activity in patients with rheumatoid arthritis. Previous studies of this treatment have all used the intravenous route and methylprednisolone succinate. This study addresses the question of whether oral prednisolone in equivalent doses can substitute for intravenous methylprednisolone in pulse therapy in a double blind parallel study. It is shown that oral prednisolone has clinical and immunological effects equivalent to those of intravenous methylprednisolone, making it possible to administer pulse therapy to patients with rheumatoid arthritis as outpatients without the inconvenience and inherent dangers of intravenous administration.

Full text

PDF
28

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barry M. The use of high-dose pulse methylprednisolone in rheumatoid arthritis. Unproved therapy. Arch Intern Med. 1985 Aug;145(8):1483–1484. [PubMed] [Google Scholar]
  2. Bertouch J. V., Roberts-Thomson P. J., Smith M. D., Woodruff T. G., Brooks P. M., Bradley J. Methylprednisolone infusion therapy in rheumatoid arthritis patients. The effect on synovial fluid lymphocyte subsets and inflammatory indices. Arthritis Rheum. 1986 Jan;29(1):32–38. doi: 10.1002/art.1780290105. [DOI] [PubMed] [Google Scholar]
  3. Conn H. O., Blitzer B. L. Nonassociation of adrenocorticosteroid therapy and peptic ulcer. N Engl J Med. 1976 Feb 26;294(9):473–479. doi: 10.1056/NEJM197602262940905. [DOI] [PubMed] [Google Scholar]
  4. Conn H. O., Poynard T. Adrenocorticosteroid administration and peptic ulcer: a critical analysis. J Chronic Dis. 1985;38(6):457–468. doi: 10.1016/0021-9681(85)90028-1. [DOI] [PubMed] [Google Scholar]
  5. Fan P. T., Yu D. T., Clements P. J., Fowlston S., Eisman J., Bluestone R. Effect of corticosteroids on the human immune response: comparison of one and three daily 1 gm intravenous pulses of methylprednisolone. J Lab Clin Med. 1978 Apr;91(4):625–634. [PubMed] [Google Scholar]
  6. Forster P. J., Grindulis K. A., Neumann V., Hubball S., McConkey B. High-dose intravenous methylprednisolone in rheumatoid arthritis. Ann Rheum Dis. 1982 Oct;41(5):444–446. doi: 10.1136/ard.41.5.444. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Liebling M. R., Leib E., McLaughlin K., Blocka K., Furst D. E., Nyman K., Paulus H. E. Pulse methylprednisolone in rheumatoid arthritis: a double-blind cross-over trial. Ann Intern Med. 1981 Jan;94(1):21–26. doi: 10.7326/0003-4819-94-1-21. [DOI] [PubMed] [Google Scholar]
  8. Makuch R., Simon R. Sample size requirements for evaluating a conservative therapy. Cancer Treat Rep. 1978 Jul;62(7):1037–1040. [PubMed] [Google Scholar]
  9. Messer J., Reitman D., Sacks H. S., Smith H., Jr, Chalmers T. C. Association of adrenocorticosteroid therapy and peptic-ulcer disease. N Engl J Med. 1983 Jul 7;309(1):21–24. doi: 10.1056/NEJM198307073090105. [DOI] [PubMed] [Google Scholar]
  10. Spiro H. M. Is the steroid ulcer a myth? N Engl J Med. 1983 Jul 7;309(1):45–47. doi: 10.1056/NEJM198307073090110. [DOI] [PubMed] [Google Scholar]
  11. Williams I. A., Baylis E. M., Shipley M. E. A double-blind placebo-controlled trial of methylprednisolone pulse therapy in active rheumatoid disease. Lancet. 1982 Jul 31;2(8292):237–240. doi: 10.1016/s0140-6736(82)90323-3. [DOI] [PubMed] [Google Scholar]
  12. Zubler R. H., Nydegger U., Perrin L. H., Fehr K., McCormick J., Lambert P. H., Miescher P. A. Circulating and intra-articular immune complexes in patients with rheumatoid arthritis. Correlation of 125I-Clq binding activity with clinical and biological features of the disease. J Clin Invest. 1976 May;57(5):1308–1319. doi: 10.1172/JCI108399. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES